关注
Marco Velasco-Velázquez
Marco Velasco-Velázquez
Profesor
在 unam.mx 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
CCR5 antagonist blocks metastasis of basal breast cancer cells
M Velasco-Velázquez, X Jiao, M De La Fuente, TG Pestell, A Ertel, ...
Cancer research 72 (15), 3839-3850, 2012
3272012
Breast cancer stem cells
MA Velasco-Velázquez, N Homsi, M De La Fuente, RG Pestell
The international journal of biochemistry & cell biology 44 (4), 573-577, 2012
2262012
Immunomodulatory effects mediated by serotonin
R Arreola, E Becerril-Villanueva, C Cruz-Fuentes, MA Velasco-Velázquez, ...
Journal of immunology research 2015 (1), 354957, 2015
2242015
The role of breast cancer stem cells in metastasis and therapeutic implications
MA Velasco-Velázquez, VM Popov, MP Lisanti, RG Pestell
The American journal of pathology 179 (1), 2-11, 2011
2072011
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
MC Casimiro, M Velasco-Velázquez, C Aguirre-Alvarado, RG Pestell
Expert opinion on investigational drugs 23 (3), 295-304, 2014
1942014
IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients
D Mendieta, DL De la Cruz-Aguilera, MI Barrera-Villalpando, ...
Journal of neuroimmunology 290, 22-25, 2016
1702016
Macrophage—Mycobacterium tuberculosis interactions: role of complement receptor 3
MA Velasco-Velázquez, D Barrera, A González-Arenas, C Rosales, ...
Microbial pathogenesis 35 (3), 125-131, 2003
1562003
CCR5 governs DNA damage repair and breast cancer stem cell expansion
X Jiao, MA Velasco-Velazquez, M Wang, Z Li, H Rui, AR Peck, JE Korkola, ...
Cancer research 78 (7), 1657-1671, 2018
1272018
The potential to target CCL5/CCR5 in breast cancer
M Velasco-Velázquez, W Xolalpa, RG Pestell
Expert opinion on therapeutic targets 18 (11), 1265-1275, 2014
1202014
Apoptotic signaling pathways in glioblastoma and therapeutic implications
SA Valdés-Rives, D Casique-Aguirre, L Germán-Castelán, ...
BioMed research international 2017 (1), 7403747, 2017
1062017
4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16–F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility
MA Velasco-Velázquez, J Agramonte-Hevia, D Barrera, ...
Cancer letters 198 (2), 179-186, 2003
1062003
Examining the role of cyclin D1 in breast cancer
MA Velasco-Velázquez, Z Li, M Casimiro, E Loro, N Homsi, RG Pestell
Future Oncology 7 (6), 753-765, 2011
942011
The CCL5/CCR5 axis promotes metastasis in basal breast cancer
M Velasco-Velázquez, RG Pestell
Oncoimmunology 2 (4), e23660, 2013
932013
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin
FA Jiménez-Orozco, JS Lopez-González, A Nieto-Rodriguez, ...
Lung Cancer 34 (2), 185-194, 2001
912001
Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3
J Agramonte-Hevia, A González-Arenas, D Barrera, ...
FEMS Immunology & Medical Microbiology 34 (4), 255-266, 2002
872002
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene–transformed metastatic prostate cancer cell lines
D Sicoli, X Jiao, X Ju, M Velasco-Velazquez, A Ertel, S Addya, Z Li, ...
Cancer research 74 (23), 7103-7114, 2014
822014
NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer
K Vazquez-Santillan, J Melendez-Zajgla, LE Jimenez-Hernandez, ...
Scientific reports 6 (1), 37340, 2016
762016
Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions
M de Lourdes Mora-García, R García-Rocha, O Morales-Ramírez, ...
Journal of Translational Medicine 14, 1-14, 2016
672016
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics
R Oerlemans, AJ Ruiz-Moreno, Y Cong, ND Kumar, ...
RSC medicinal chemistry 12 (3), 370-379, 2021
652021
Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK–LKB1 signaling axis
MC Casimiro, G Di Sante, A Di Rocco, E Loro, C Pupo, TG Pestell, ...
Cancer research 77 (13), 3391-3405, 2017
572017
系统目前无法执行此操作,请稍后再试。
文章 1–20